Source:http://linkedlifedata.com/resource/pubmed/id/15458277
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2004-10-1
|
pubmed:abstractText |
We aimed to determine the correlations between standard clinicopathological factors and expression of c-erbB-2 and p53 proteins, and to investigate the significance of these variables in relapse and disease-free survival (DFS) in breast carcinoma patients. Data from 200 patients who had undergone mastectomy for breast carcinoma were evaluated. Significant correlations were found between c-erbB-2 positivity and high histological grade (grade 3) tumour, p53 positivity and high grade tumour, and age < 60 years and oestrogen receptor negativity. Twenty-six patients (13%) developed a recurrence. Disease relapse was more frequent in patients who had axillary lymph node (ALN) metastasis, high grade tumour, c-erbB-2 positivity and p53 positivity; these variables were also associated with a shorter DFS. The effects of ALN metastasis and p53 positivity were significant. In conclusion, ALN metastasis and p53 positivity were important factors for predicting disease relapse in mastectomy-treated breast carcinoma patients; other clinicopathological criteria and c-erbB-2 positivity were not predictive.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-0605
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
455-64
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:15458277-Adult,
pubmed-meshheading:15458277-Aged,
pubmed-meshheading:15458277-Aged, 80 and over,
pubmed-meshheading:15458277-Breast Neoplasms,
pubmed-meshheading:15458277-Disease-Free Survival,
pubmed-meshheading:15458277-Female,
pubmed-meshheading:15458277-Humans,
pubmed-meshheading:15458277-Middle Aged,
pubmed-meshheading:15458277-Multivariate Analysis,
pubmed-meshheading:15458277-Neoplasm Metastasis,
pubmed-meshheading:15458277-Prognosis,
pubmed-meshheading:15458277-Receptor, erbB-2,
pubmed-meshheading:15458277-Receptors, Estrogen,
pubmed-meshheading:15458277-Recurrence,
pubmed-meshheading:15458277-Retrospective Studies,
pubmed-meshheading:15458277-Survival Rate,
pubmed-meshheading:15458277-Tumor Suppressor Protein p53
|
pubmed:articleTitle |
Expression of c-erbB-2 and p53 in breast carcinoma patients: comparison with traditional prognostic factors and survival.
|
pubmed:affiliation |
School of Medicine, Department of General Surgery, Akdeniz University, Kampiis, 07070 Antalya, Turkey.
|
pubmed:publicationType |
Journal Article
|